Nate Nguyen - Mar 29, 2024 Form 3 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Interim PAO and PFO
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Mar 29, 2024
Transactions value $
$0
Form type
3
Date filed
4/2/2024, 08:50 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGEM Common Stock 6.25K Mar 29, 2024 Direct F1
holding CGEM Common Stock 13.4K Mar 29, 2024 Direct F2
holding CGEM Common Stock 13.4K Mar 29, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CGEM Stock Option (Right to Buy) Mar 29, 2024 Common Stock 75K $48.39 Direct F4
holding CGEM Stock Option (Right to Buy) Mar 29, 2024 Common Stock 62.5K $13.60 Direct F5
holding CGEM Stock Option (Right to Buy) Mar 29, 2024 Common Stock 26.8K $11.34 Direct F6
holding CGEM Stock Option (Right to Buy) Mar 29, 2024 Common Stock 26.8K $17.54 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of February 11, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2 The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of February 17, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
F3 The shares underlying the restricted stock unit vest over four years until the fourth anniversary of February 22, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
F4 25% of the shares vested on January 25, 2022, and the remaining shares vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F5 The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of February 11, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
F6 The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of February 17, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
F7 The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of February 22, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.

Remarks:

Exhibit 24 - Power of Attorney